Hvornår offentliggør Neurocrine Biosciences, Inc. en resultatopgørelse?
Neurocrine Biosciences, Inc. resultatopgørelse offentliggøres en gang i kvartalet, den seneste årsregnskab for Neurocrine Biosciences, Inc. blev offentliggjort den 31/03/2021.
Hvad er fortjenesten fra aktierne i Neurocrine Biosciences, Inc.?
Anslået indtjening pr. aktie i Neurocrine Biosciences, Inc. var 0.33 $ i den sidste regnskabsrapport.
Hvornår vil Neurocrine Biosciences, Inc. offentliggøre næste resultatopgørelse?
Den næste rapport om resultatopgørelsen Neurocrine Biosciences, Inc. vil offentliggøres i Juni 2024.
Neurocrine Biosciences, Inc. indtjening pr. Aktie i virksomheden - en af indikatorerne for virksomhedens indtægter fra størrelsen af dens værdi. Resultat pr. Aktie - beregnet værdi: den samlede fortjeneste for rapporteringsperioden divideres med antallet af eksisterende aktier. Neurocrine Biosciences, Inc. indtjening pr. Aktie er naturligvis en variabel indikator for en bestemt finansieringsperiode. Fortjeneste ved Neurocrine Biosciences, Inc. - organisationens rapporterede fortjeneste for det økonomiske interval, der er angivet i loven.
|
Fortjeneste Neurocrine Biosciences, Inc.
Overskud for hele virksomheden Neurocrine Biosciences, Inc. er vigtigere for ledelsen af ledere end selskabets aktionærer. Mere vigtigt er beregningen af indtjening pr. Aktie. Denne værdi er grundlaget for beregning af udbytte og efterspørges meget mere af aktionærerne. Datoen for resultatrapporten Neurocrine Biosciences, Inc. er knyttet til lovgivningen i det land, hvor selskabet er registreret. Hver dato i Neurocrine Biosciences, Inc. resultatopgørelse svarer til en linje i servicetabellen.
|
Kvartalsresultatet Neurocrine Biosciences, Inc.
Resultat pr. Aktie Neurocrine Biosciences, Inc. beregnes ved at dividere nettoresultatet med antallet af aktier i virksomheden. Earnings per share of Neurocrine Biosciences, Inc. is considered for a certain financial period as well as financial reports on the company's total profit are issued. Neurocrine Biosciences, Inc. earnings per share for today or for the last reporting interval can be seen in the table on the top line. Neurocrine Biosciences, Inc. quarterly earnings for financial analytics is the main interim report for the financial year.
|
|
NBIX rapport dato
|
Indtjening pr. aktie
Resultat pr. aktie beregnes ved at dividere nettoindkomst (eller overskud) med antallet af aktier i selskabet.
|
Ændring i det sidste år %
|
|
31/03/2021 |
0.33 USD |
- |
|
31/12/2020 |
3.58 USD |
+922.86% ↑ |
|
30/09/2020 |
-0.62 USD |
-210.714% ↓ |
|
30/06/2020 |
0.81 USD |
+50% ↑ |
|
31/12/2019 |
0.35 USD |
+310.58% ↑ |
|
30/09/2019 |
0.56 USD |
+39.89% ↑ |
|
30/06/2019 |
0.54 USD |
-165.562% ↓ |
|
31/03/2019 |
-1.12 USD |
-67.0652% ↓ |
|
31/12/2018 |
0.19 USD |
+0.62% ↑ |
|
30/09/2018 |
0.52 USD |
-195.148% ↓ |
|
30/06/2018 |
-0.07 USD |
-74.675% ↓ |
|
31/03/2018 |
-0.47 USD |
-58.822% ↓ |
|
31/12/2017 |
0.07 USD |
-132.178% ↓ |
|
30/09/2017 |
-0.13 USD |
-15.347% ↓ |
|
30/06/2017 |
-0.68 USD |
-25.535% ↓ |
|
31/03/2017 |
-0.9 USD |
-61.268% ↓ |
|
31/12/2016 |
-0.51 USD |
-43.026% ↓ |
|
30/09/2016 |
-0.43 USD |
-55.546% ↓ |
|
30/06/2016 |
-0.46 USD |
-41.976% ↓ |
|
31/03/2016 |
-0.22 USD |
-5% ↓ |
|
31/12/2015 |
-0.34 USD |
-24.298% ↓ |
|
30/09/2015 |
-0.4 USD |
-16.832% ↓ |
|
30/06/2015 |
-0.28 USD |
-36.535% ↓ |
|
31/03/2015 |
-0.01 USD |
-35.417% ↓ |
|
31/12/2014 |
-0.26 USD |
-28.768% ↓ |
|
30/09/2014 |
-0.21 USD |
-3.571% ↓ |
|
30/06/2014 |
-0.18 USD |
-6.235% ↓ |
|
31/03/2014 |
-0.17 USD |
-7.742% ↓ |
|
31/12/2013 |
-0.16 USD |
-54.566% ↓ |
|
30/09/2013 |
-0.17 USD |
-73.896% ↓ |
|
30/06/2013 |
-0.18 USD |
-85.378% ↓ |
|
31/03/2013 |
-0.18 USD |
-96.269% ↓ |
|
31/12/2012 |
0.14 USD |
-119.048% ↓ |
|
30/09/2012 |
-0.05 USD |
-459.44% ↓ |
|
30/06/2012 |
-0.01 USD |
-325.909% ↓ |
|
31/03/2012 |
-0.01 USD |
-899.55% ↓ |
|
31/12/2011 |
0.02 USD |
-155.533% ↓ |
|
30/09/2011 |
0.56 USD |
+307.11% ↑ |
|
30/06/2011 |
0.04 USD |
-136.924% ↓ |
|
31/03/2011 |
0.05 USD |
-122.089% ↓ |
|
31/12/2010 |
0.04 USD |
-113.989% ↓ |
|
30/09/2010 |
0.06 USD |
-113.259% ↓ |
|
30/06/2010 |
-0.09 USD |
-56.668% ↓ |
|
31/03/2010 |
-0.19 USD |
-37.896% ↓ |
|
31/12/2009 |
-0.2 USD |
-44.758% ↓ |
|
30/09/2009 |
-0.21 USD |
-31.348% ↓ |
|
30/06/2009 |
-0.39 USD |
-22.807% ↓ |
|
31/03/2009 |
-0.51 USD |
-29.638% ↓ |
|
31/12/2008 |
-0.75 USD |
-41.418% ↓ |
|
30/09/2008 |
-0.46 USD |
-34.434% ↓ |
|
30/06/2008 |
-0.55 USD |
-28.737% ↓ |
|
31/03/2008 |
-0.55 USD |
-16.483% ↓ |
|
31/12/2007 |
-0.89 USD |
-9.984% ↓ |
|
30/09/2007 |
-0.72 USD |
-14.469% ↓ |
|
30/06/2007 |
-0.69 USD |
-0.868% ↓ |
|
31/03/2007 |
-0.68 USD |
-4.515% ↓ |
|
31/12/2006 |
-0.39 USD |
-8.00771% ↓ |
|
30/09/2006 |
-1.03 USD |
-152.864% ↓ |
|
30/06/2006 |
-0.73 USD |
-67.277% ↓ |
|
31/03/2006 |
-0.69 USD |
-1.0294% ↓ |
|
31/12/2005 |
-0.65 USD |
-50.346% ↓ |
|
30/09/2005 |
0.68 USD |
-223.254% ↓ |
|
30/06/2005 |
-0.15 USD |
-11.546% ↓ |
|
31/03/2005 |
-0.51 USD |
-42.39% ↓ |
|
31/12/2004 |
-0.57 USD |
-59.785% ↓ |
|
30/09/2004 |
-0.05 USD |
-7.559% ↓ |
|
30/06/2004 |
-0.31 USD |
-29.824% ↓ |
|
31/03/2004 |
-0.35 USD |
-3.239% ↓ |
|
31/12/2003 |
0.09 USD |
-83.529% ↓ |
|
30/09/2003 |
-0.31 USD |
-55.522% ↓ |
|
30/06/2003 |
-0.33 USD |
-44.39% ↓ |
|
31/03/2003 |
-0.43 USD |
-42.132% ↓ |
|
31/12/2002 |
-1.27 USD |
- |
|
30/09/2002 |
-0.66 USD |
- |
|
30/06/2002 |
-0.65 USD |
- |
|
31/03/2002 |
-0.52 USD |
- |
Neurocrine Biosciences, Inc. quarterly earnings per share is a measure of the company's profitability. But it is less demanded than the profit for the year on one share. Last quarterly profit Neurocrine Biosciences, Inc. today is the officially declared profit for the last reference quarter. Change in profit Neurocrine Biosciences, Inc. for the year is a calculated value for additional information that shows the change in percentage of profit with the same interval of the last year. The change in quarterly profit of Neurocrine Biosciences, Inc. is a less significant value relative to the change in annual profit of Neurocrine Biosciences, Inc..
The change in profit is shown as a percentage. Resultathistorikken for Neurocrine Biosciences, Inc. for de seneste år og rapporteringsperioder findes i tabellen "Kvartalsvis overskud". Neurocrine Biosciences, Inc. kvartalsvis indtjeningshistorie er tilgængelig online i de sidste 10 år. Virksomhedens Neurocrine Biosciences, Inc. overskudsdatabase for tidligere år er samlet fra åbne kilder.
|
